The study has been included in the "2021 Hot Articles" list of the scientific journal Physical Chemistry Chemical Physics
Read moreThe first systematic study of its kind describes how human viruses including SARS-CoV-2 are better adapted to infecting certain types of tissues based on their ability to hijack cellular machinery ...
Read moreInvestigadores del Instituto de Biomedicina de Sevilla–IBiS/Hospital Universitario Virgen del Rocío/US/CSIC han publicado recientemente un artículo en la revista Frontiers in Cell and Developmenta...
Read more Investigadores del Instituto de Investigación Sanitaria Biodonostia pertenecientes al Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), acaban de p...
Read moreEl IBSAL adquiere un equipamiento que permitirá producir células CAR-T y purificar y expandir otras poblaciones celulares para uso clínico en un sistema cerrado
Read moreUn estudio del Instituto de Investigación Sanitaria INCLIVA, del Hospital Clínico de València, ha permitido identificar un perfil molecular en sangre y orina asociado al desarrollo de enfermedad re...
Read moreEsta nueva herramienta, desarrollada por un equipo de investigación del Departamento de Matemáticas de la Universidad de Cádiz y del Instituto de Investigación e Innovación Biomédica de Cádiz (...
Read moreAs an approach to personalised medicine, the work proposes the HMCES sensor of DNA damage as a target to treat some of the most aggressive types of lung tumours. The results have been published in PL...
Read moreEl Hospital Universitario Fundación Jiménez Díaz ha celebrado recientemente una Jornada de actualización en el tratamiento de la leucemia mieloide aguda (LMA) y la mastocitosis, un encuentro onlin...
Read moreThe companies will combine their advanced technologies to provide an individualized vaccine design for patients with no treatment options
Read moreSpain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
Read moreThe researchers conducted an in-depth study of resistance to temozolomide, the first-line treatment for glioblastoma, to which many patients cease to respond over time
Read more